# Biotricity Inc.: filings

BTCY · OTC · CIK 1630113 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/btcy.md) · [Financials](/companies/btcy/financials.md) · [Filings](/companies/btcy/filings.md) · [Insiders](/companies/btcy/insiders.md)

## Reports and events: 187 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 113, 10-Q 33, CORRESP 17, UPLOAD 16, S-1/A 13, 4 12, 10-K 11, 3 8, 424B3 8, EFFECT 8, NT 10-Q 8, SCHEDULE 13G/A 7, 424B5 6, NT 10-K 6, D 5, S-1 5, S-3 5, S-3/A 4, 10-Q/A 3, 8-K/A 3, DEF 14A 3, PRE 14A 3, 10-K/A 2, 10-KT 2, DEFA14A 2, RW 2, 25-NSE 1, 4/A 1, 8-A12B 1, 8-A12G 1, CERT 1, CT ORDER 1, D/A 1, DEF 14C 1, PRE 14C 1, SC 13D 1, SC 13G 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 23:04 ET | [8-K](/filings/0001493152-26-044407.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-044407 |
| 2026-08-19 | 20:05 ET | [10-Q](/filings/0001493152-26-039209.md) | Quarterly report, period 2026-06-30 | 0001493152-26-039209 |
| 2026-07-14 | 21:25 ET | [10-K](/filings/0001493152-26-033207.md) | Annual report, period 2026-03-31 | 0001493152-26-033207 |
| 2026-05-01 | 21:28 ET | [8-K](/filings/0001493152-26-020939.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-020939 |
| 2026-02-18 | 22:30 ET | [8-K](/filings/0001493152-26-007369.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-007369 |
| 2026-02-11 | 21:29 ET | [10-Q](/filings/0001493152-26-006211.md) | Quarterly report, period 2025-12-31 | 0001493152-26-006211 |
| 2025-12-19 | 22:29 ET | [S-1](/filings/0001493152-25-028614.md) | Registration statement | 0001493152-25-028614 |
| 2025-11-18 | 21:05 ET | [8-K](/filings/0001493152-25-024061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-024061 |
| 2025-11-14 | 20:38 ET | [10-Q](/filings/0001493152-25-023361.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023361 |
| 2025-08-14 | 11:01 ET | [10-Q](/filings/0001641172-25-023709.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023709 |
| 2025-07-18 | 00:04 ET | [10-K/A](/filings/0001641172-25-020105.md) | Annual report, amended, period 2025-03-31 | 0001641172-25-020105 |
| 2025-07-15 | 21:27 ET | [10-K](/filings/0001641172-25-019755.md) | Annual report, period 2025-03-31 | 0001641172-25-019755 |
| 2025-02-24 | 22:45 ET | [8-K](/filings/0001493152-25-007938.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-007938 |
| 2025-02-20 | 17:08 ET | [10-Q/A](/filings/0001493152-25-007664.md) | Quarterly report, amended, period 2024-12-31 | 0001493152-25-007664 |
| 2025-02-19 | 22:30 ET | [10-Q](/filings/0001493152-25-007608.md) | Quarterly report, period 2024-12-31 | 0001493152-25-007608 |
| 2024-11-20 | 02:41 ET | [8-K](/filings/0001493152-24-046908.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-046908 |
| 2024-11-14 | 22:02 ET | [10-Q](/filings/0001493152-24-046028.md) | Quarterly report, period 2024-09-30 | 0001493152-24-046028 |
| 2024-08-19 | 21:24 ET | [10-Q](/filings/0001493152-24-033159.md) | Quarterly report, period 2024-06-30 | 0001493152-24-033159 |
| 2024-08-16 | 21:01 ET | [8-K](/filings/0001493152-24-032861.md) | 5.07 Shareholder vote results | 0001493152-24-032861 |
| 2024-08-07 | 21:30 ET | [8-K](/filings/0001493152-24-030615.md) | 3.01 Delisting notice | 0001493152-24-030615 |
| 2024-08-05 | 12:48 ET | [DEF 14A](/filings/0001493152-24-030135.md) | Proxy statement, period 2024-08-02 | 0001493152-24-030135 |
| 2024-08-01 | 21:07 ET | [8-K](/filings/0001493152-24-029939.md) | 3.01 Delisting notice | 0001493152-24-029939 |
| 2024-07-16 | 21:26 ET | [8-K](/filings/0001493152-24-028050.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-028050 |
| 2024-07-12 | 20:12 ET | [8-K](/filings/0001493152-24-027090.md) | 5.07 Shareholder vote results | 0001493152-24-027090 |
| 2024-06-28 | 20:15 ET | [DEF 14A](/filings/0001493152-24-025614.md) | Proxy statement, period 2024-06-28 | 0001493152-24-025614 |
| 2024-06-28 | 23:55 ET | [10-K/A](/filings/0001493152-24-025493.md) | Annual report, amended, period 2024-03-31 | 0001493152-24-025493 |
| 2024-06-27 | 01:58 ET | [10-K](/filings/0001493152-24-025344.md) | Annual report, period 2024-03-31 | 0001493152-24-025344 |
| 2024-06-24 | 13:25 ET | [8-K](/filings/0001493152-24-024888.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-024888 |
| 2024-06-07 | 20:34 ET | [8-K](/filings/0001493152-24-023126.md) | 3.02 Unregistered sale of equity | 0001493152-24-023126 |
| 2024-05-28 | 11:31 ET | [8-K](/filings/0001493152-24-021454.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-021454 |
| 2024-05-21 | 21:00 ET | [8-K](/filings/0001493152-24-020909.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020909 |
| 2024-05-03 | 20:59 ET | [8-K](/filings/0001493152-24-017744.md) | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017744 |
| 2024-04-23 | 21:16 ET | [8-K](/filings/0001493152-24-015713.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015713 |
| 2024-04-03 | 10:07 ET | [8-K](/filings/0001493152-24-012898.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-012898 |
| 2024-03-26 | 21:18 ET | [8-K](/filings/0001493152-24-011344.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-011344 |
| 2024-02-28 | 01:45 ET | [S-1](/filings/0001493152-24-008031.md) | Registration statement | 0001493152-24-008031 |
| 2024-02-20 | 22:02 ET | [10-Q](/filings/0001493152-24-007244.md) | Quarterly report, period 2023-12-31 | 0001493152-24-007244 |
| 2024-02-02 | 22:30 ET | [8-K](/filings/0001493152-24-004806.md) | 3.01 Delisting notice | 0001493152-24-004806 |
| 2023-11-14 | 21:57 ET | [10-Q](/filings/0001493152-23-041243.md) | Quarterly report, period 2023-09-30 | 0001493152-23-041243 |
| 2023-11-06 | 21:55 ET | [8-K](/filings/0001493152-23-039557.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-039557 |
| 2023-09-20 | 12:15 ET | [8-K](/filings/0001493152-23-033139.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-033139 |
| 2023-08-17 | 12:38 ET | [8-K](/filings/0001493152-23-029242.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-029242 |
| 2023-08-14 | 20:26 ET | [10-Q](/filings/0001493152-23-028510.md) | Quarterly report, period 2023-06-30 | 0001493152-23-028510 |
| 2023-08-04 | 20:15 ET | [8-K](/filings/0001493152-23-026879.md) | 3.01 Delisting notice | 0001493152-23-026879 |
| 2023-07-20 | 21:14 ET | [8-K](/filings/0001493152-23-025121.md) | 8.01 Other events | 0001493152-23-025121 |
| 2023-07-05 | 20:05 ET | [8-K](/filings/0001493152-23-023428.md) | 2.02 Results of operations; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-023428 |
| 2023-06-29 | 21:29 ET | [10-K](/filings/0001493152-23-022974.md) | Annual report, period 2023-03-31 | 0001493152-23-022974 |
| 2023-05-18 | 20:41 ET | [8-K](/filings/0001493152-23-018125.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-018125 |
| 2023-04-03 | 21:16 ET | [8-K](/filings/0001493152-23-010668.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-010668 |
| 2023-03-13 | 20:21 ET | [DEF 14A](/filings/0001493152-23-007414.md) | Proxy statement, period 2023-03-13 | 0001493152-23-007414 |

Page 1 of 4. [Older](/companies/btcy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.